Immunologic Procedures HARR Flashcards
The interaction between an individual antigen
and antibody molecule depends upon several
types of bonds such as ionic bonds, hydrogen
bonds, hydrophobic bonds, and van der Waals
forces. How is the strength of this attraction
characterized?
A. Avidity
B. Affinity
C. Reactivity
D. Valency
Affinity
Affinity refers to the strength of a single antibody–antigen interaction. Avidity is the strength of interactions between many different antibodies in a serum against a particular antigen (i.e., the sum of many affinities).
A laboratory is evaluating an enzyme-linked
immunosorbent assay (ELISA) for detecting an
antibody to cyclic citrullinated peptide (CCP),
which is a marker for rheumatoid arthritis. The
laboratory includes serum from healthy volunteers and patients with other connective tissue diseases in the evaluation. These specimens determine which factor of the assay?
A. Sensitivity
B. Precision
C. Bias
D. Specificity
Specificity
Specificity is defined as a negative result in the
absence of the disease. The non–rheumatoid
arthritis specimens would be expected to test
negative if the assay has high specificity. Precision is the ability of the assay to repeatedly yield the same results on a single specimen. Both bias and sensitivity calculations would include specimens from rheumatoid arthritis specimens. Although
those specimens would be included in the
evaluation, they are not listed in the question.
The detection of precipitation reactions depends on the presence of optimal proportions of antigen and antibody. A patient’s sample contains a large amount of antibody, but the reaction in a test system
containing antigen is negative. What has happened?
A. Performance error
B. Low specificity
C. A shift in the zone of equivalence
D. Prozone phenomenon
Prozone phenomenon
Although performance error and low specificity
should be considered, if a test system fails to yield the expected reaction, excessive antibody
preventing a precipitation reaction is usually the cause. Prozone occurs when antibody molecules saturate the antigen sites, preventing cross linking of the antigen–antibody complexes by other antibody molecules. Because the antigen and antibody do not react at equivalence, a visible product is not formed, leading to a false-negative result.
Which part of the radial immunodiffusion (RID) test system contains the antisera?
A. Center well
B. Outer wells
C. Gel
D. Antisera may be added to any well
Gel
In an RID test system, for example, one measuring hemopexin concentration, the gel would contain the antihemopexin. A standardized volume of serum containing the antigen is added to each well. Antigen diffuses from the well into the gel and forms a precipitin ring by reaction with antibody. At
equivalence, the area of the ring is proportional to antigen concentration.
What is the interpretation when an Ouchterlony plate shows crossed lines between wells 1 and 2 (antigen is placed in the center well and antisera in wells 1 and 2)?
A. No reaction between wells 1 and 2
B. Partial identity between wells 1 and 2
C. Nonidentity between wells 1 and 2
D. Identity between wells 1 and 2
Nonidentity between wells 1 and 2
Crossed lines indicate nonidentity between
wells 1 and 2. The antibody from well 1 recognizes a different antigenic determinant than the antibody from well 2.
Why is a chemiluminescent immunoassay (CIA) or enzyme immunoassay (EIA) the method of choice for detection of certain analytes, such as hormones, normally found in low concentrations?
A. Because of low cross reactivity
B. Because of high specificity
C. Because of high sensitivity
D. Because test systems may be designed as both competitive and noncompetitive assays
Because of high sensitivity
The sensitivity of EIA methods producing visible color change, and fluorescent and chemiluminescent products approaches nanogram levels of antibody. These methods are easily automated.
What comprises the indicator system in an indirect ELISA for detecting antibody?
A. Enzyme-conjugated antibody + chromogenic
substrate
B. Enzyme conjugated antigen + chromogenic
substrate
C. Enzyme + antigen
D. Substrate + antigen
Enzyme-conjugated antibody + chromogenic
substrate
The ELISA test measures antibody using immobilized reagent antigen. The antigen is fixed to the walls of a tube or bottom of a microtiter well. Serum is added (and incubated) and the antibody binds, if present. After washing, the antigen–antibody complexes are detected by adding an enzyme
labeled anti-immunoglobulin. The unbound
enzyme label is removed by washing, and the
bound enzyme label is detected by adding
chromogenic substrate. The enzyme catalyzes the conversion of substrate to colored product
What outcome results from improper washing of a tube or well after adding the enzyme–antibody conjugate in an ELISA system?
A. Result will be falsely decreased
B. Result will be falsely increased
C. Result will be unaffected
D. Result is impossible to determine
Result will be falsely increased
If unbound enzyme-conjugated anti-immunoglobulin is not washed away, it will catalyze conversion of substrate to colored product, yielding a falsely elevated result
What would happen if the color reaction phase is prolonged in one tube or well of an ELISA test?
A. Result will be falsely decreased
B. Result will be falsely increased
C. Result will be unaffected
D. Impossible to determine
Result will be falsely increased
If the color reaction is not stopped within the time limits specified by the procedure, the enzyme will continue to act on the substrate, producing a falsely elevated test result.
The absorbance of a sample measured by ELISA is greater than the highest standard. What corrective action should be taken?
A. Extrapolate an estimated value from the highest reading
B. Repeat the test using a standard of higher
concentration
C. Repeat the assay using one half the volume of the sample
D. Dilute the test sample
Dilute the test sample
Usually when a test sample reads at a value above the highest standard in an ELISA test, it is diluted and measured again. In those instances where no additional clinical value can be obtained by dilution, the result may be reported as greater than the highest standard (citing the upper reportable limit of the assay).
A patient was suspected of having a
lymphoproliferative disorder. After several
laboratory tests were completed, the patient was found to have an IgMκ paraprotein. In what sequence should the laboratory tests leading to this diagnosis have been performed?
A. Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE)
B. Immunoglobulin levels followed by SPE
C. Total lymphocyte count followed by
immunoglobulin levels
D. Immunoglobulin levels followed by urine protein electrophoresis
Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE)
Serum protein electrophoresis should be performed initially to detect the presence of an abnormal immunoglobulin that demonstrates restricted electrophoretic mobility. A patient producing only monoclonal light chains may not show any abnormal serum finding because the light chains may be excreted in the urine. A positive finding for either serum or urine should be followed by IFE on the positive specimen. This is required to confirm the
presence of monoclonal immunoglobulin and to identify the heavy and light chain type
An IFE performed on a serum sample showed a narrow dark band in the lanes containing anti-γ and anti-λ. How should this result be interpreted?
A. Abnormally decreased IgG concentration
B. Abnormal test result demonstrating monoclonal IgGλ
C. Normal test result
D. Impossible to determine without densitometric quantitation
Abnormal test result demonstrating monoclonal IgGλ
A narrow dark band formed in both the lane
containing anti-γ and anti-λ indicates the
presence of a monoclonal IgG λ immunoglobulin. A diffuse dark band would indicate a polyclonal increase in IgG that often accompanies chronic inflammatory disorders such as systemic lupus erythematosus (SLE).
Which type of nephelometry is used to measure immune complex formation almost immediately after reagent has been added?
A. Rate
B. Endpoint
C. Continuous
D. One dimensional
Rate
Rate nephelometry is used to measure formation of small immune complexes as they are formed under conditions of antibody excess. The rate of increase in photodetector output is measured within seconds or minutes and increases with increasing antigen concentration. Antigen concentration is determined by comparing the rate for the sample to that for standards using an
algorithm that compensates for nonlinearity. In endpoint nephelometry, reactions are read after equivalence. Immune complexes are of maximal size but may have a tendency to settle out of solution, thereby decreasing the amount of scatter.
An immunofluorescence microscopy assay (IFA) was performed, and a significant antibody titer was reported. Positive and negative controls performed as expected. However, the clinical evaluation of the patient was not consistent with a positive finding. What is the most likely explanation of this situation?
A. The clinical condition of the patient changed
since the sample was tested
B. The pattern of fluorescence was misinterpreted
C. The control results were misinterpreted
D. The wrong cell line was used for the test
The pattern of fluorescence was misinterpreted
In an IFA, for example, an antinuclear antibody
(ANA) test, the fluorescence pattern must be
correlated correctly with the specificity of the
antibodies. Both pathological and nonpathological antibodies can occur, and antibodies may be detected at a significant titer in a patient whose disease is inactive. Failure to correctly identify subcellular structures may result in misinterpretation
of the antibody specificity, or a false positive
caused by nonspecific fluorescence
What corrective action should be taken when an indeterminate pattern occurs in an indirect IFA?
A. Repeat the test using a larger volume of sample
B. Call the physician
C. Have another medical laboratory scientist read the slide
D. Dilute the sample and retest
Dilute the sample and retest
An unexpected pattern may indicate the presence of more than one antibody. Diluting the sample may help to clearly show the antibody specificities, if they are found in different titers. If the pattern is still atypical, a new sample should be collected and the test repeated